If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
10th Apr 20188:14 amRNSDirector/PDMR Shareholding
9th Apr 20185:19 pmRNSIssue of Equity
4th Apr 20185:10 pmRNSNet Asset Value(s)
4th Apr 201811:21 amRNSCompliance with Market Abuse Regulation
3rd Apr 20189:38 amRNSTotal Voting Rights
29th Mar 20182:29 pmRNSTransaction in Own Shares
27th Mar 20183:49 pmRNSIssue of Equity
26th Mar 201811:41 amRNSNet Asset Value(s)
23rd Mar 20185:45 pmRNSTransaction in Own Shares
20th Mar 20185:23 pmRNSIssue of Equity
19th Mar 20183:15 pmRNSNet Asset Value(s)
19th Mar 20181:31 pmRNSHolding(s) in Company
13th Mar 20182:30 pmRNSTransaction in Own Shares
12th Mar 20183:07 pmRNSNet Asset Value(s)
9th Mar 20185:47 pmRNSIssue of a Supplementary Prospectus and Circular
2nd Mar 20185:03 pmRNSNet Asset Value(s)
1st Mar 201810:07 amRNSTotal Voting Rights
28th Feb 20188:02 amRNSIssue of Equity - replacement
27th Feb 20183:45 pmRNSDirector/PDMR Shareholding
27th Feb 20183:39 pmRNSIssue of Equity
26th Feb 20183:11 pmRNSNet Asset Value(s)
23rd Feb 20183:39 pmRNSTransaction in Own Shares
20th Feb 201811:00 amRNSNet Asset Value(s)
15th Feb 20182:02 pmRNSTransaction in Own Shares
12th Feb 20184:27 pmRNSNet Asset Value(s)
5th Feb 20181:46 pmRNSTransaction in Own Shares
2nd Feb 20182:38 pmRNSNet Asset Value(s)
1st Feb 20188:10 amRNSTotal Voting Rights
31st Jan 201810:07 amRNSDirector/PDMR Shareholding
30th Jan 20185:11 pmRNSIssue of Equity
29th Jan 20185:01 pmRNSNet Asset Value(s)
22nd Jan 20185:07 pmRNSNet Asset Value(s)
22nd Jan 201811:16 amRNSTransaction in Own Shares
19th Jan 201811:38 amRNSTransaction in Own Shares
18th Jan 201810:07 amRNSDirector Declaration
15th Jan 20184:53 pmRNSNet Asset Value(s)
4th Jan 20183:20 pmRNSNet Asset Value(s)
3rd Jan 20187:29 amRNSTotal Voting Rights
28th Dec 201710:26 amRNSTransaction in Own Shares
27th Dec 20177:00 amRNSNet Asset Value(s)
19th Dec 20174:39 pmRNSIssue of Equity
18th Dec 20174:15 pmRNSNet Asset Value(s)
18th Dec 201710:14 amRNSTransaction in Own Shares
11th Dec 20175:31 pmRNSNet Asset Value(s)
8th Dec 201712:25 pmRNSTransaction in Own Shares
6th Dec 201710:27 amRNSHolding(s) in Company
4th Dec 20174:22 pmRNSNet Asset Value(s)
1st Dec 20175:05 pmRNSTransaction in Own Shares
1st Dec 20179:27 amRNSTotal Voting Rights
29th Nov 201711:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.